{"pmid":32470620,"title":"Invasive pulmonary aspergillosis complicating SARS-CoV-2 pneumonia: A diagnostic challenge.","text":["Invasive pulmonary aspergillosis complicating SARS-CoV-2 pneumonia: A diagnostic challenge.","Travel Med Infect Dis","Antinori, Spinello","Rech, Roberto","Galimberti, Laura","Castelli, Antonio","Angeli, Elena","Fossali, Tommaso","Bernasconi, Davide","Covizzi, Alice","Bonazzetti, Cecilia","Torre, Alessandro","Carsana, Luca","Tonello, Cristina","Zerbi, Pietro","Nebuloni, Manuela","32470620"],"journal":"Travel Med Infect Dis","authors":["Antinori, Spinello","Rech, Roberto","Galimberti, Laura","Castelli, Antonio","Angeli, Elena","Fossali, Tommaso","Bernasconi, Davide","Covizzi, Alice","Bonazzetti, Cecilia","Torre, Alessandro","Carsana, Luca","Tonello, Cristina","Zerbi, Pietro","Nebuloni, Manuela"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32470620","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.tmaid.2020.101752","topics":["Case Report"],"weight":1,"_version_":1668167109997232128,"score":9.490897,"similar":[{"pmid":32395423,"pmcid":"PMC7211620","title":"Invasive pulmonary aspergillosis complicating COVID-19 in the ICU - A case report.","text":["Invasive pulmonary aspergillosis complicating COVID-19 in the ICU - A case report.","It is not yet known, if critically ill COVID-19 patients are prone to fungal infections. We report a 69-year-old patient without typical risk factors for invasive pulmonary aspergillosis (IPA), who developed IPA two weeks after onset of symptoms. Our report shows that IPA may occur in critically ill COVID-19 patients.","Med Mycol Case Rep","Prattes, Juergen","Valentin, Thomas","Hoenigl, Martin","Talakic, Emina","Reisinger, Alexander C","Eller, Philipp","32395423"],"abstract":["It is not yet known, if critically ill COVID-19 patients are prone to fungal infections. We report a 69-year-old patient without typical risk factors for invasive pulmonary aspergillosis (IPA), who developed IPA two weeks after onset of symptoms. Our report shows that IPA may occur in critically ill COVID-19 patients."],"journal":"Med Mycol Case Rep","authors":["Prattes, Juergen","Valentin, Thomas","Hoenigl, Martin","Talakic, Emina","Reisinger, Alexander C","Eller, Philipp"],"date":"2020-05-13T11:00:00Z","year":2020,"_id":"32395423","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.mmcr.2020.05.001","keywords":["aspergillosis","covid-19","icu"],"topics":["Case Report"],"weight":1,"_version_":1666627827935477760,"score":65.55088},{"pmid":32488446,"pmcid":"PMC7265874","title":"COVID-19-associated invasive pulmonary aspergillosis.","text":["COVID-19-associated invasive pulmonary aspergillosis.","Ann Intensive Care","Rutsaert, Lynn","Steinfort, Nicky","Van Hunsel, Tine","Bomans, Peter","Naesens, Reinout","Mertes, Helena","Dits, Hilde","Van Regenmortel, Niels","32488446"],"journal":"Ann Intensive Care","authors":["Rutsaert, Lynn","Steinfort, Nicky","Van Hunsel, Tine","Bomans, Peter","Naesens, Reinout","Mertes, Helena","Dits, Hilde","Van Regenmortel, Niels"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32488446","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1186/s13613-020-00686-4","topics":["Case Report"],"weight":1,"_version_":1668892169441640448,"score":65.46984},{"pmid":32502643,"pmcid":"PMC7264932","title":"Invasive pulmonary aspergillosis in severe COVID-19 pneumonia.","text":["Invasive pulmonary aspergillosis in severe COVID-19 pneumonia.","Clin Microbiol Infect","Lahmer, Tobias","Rasch, Sebastian","Spinner, Christoph","Geisler, Fabian","Schmid, Roland M","Huber, Wolfgang","32502643"],"journal":"Clin Microbiol Infect","authors":["Lahmer, Tobias","Rasch, Sebastian","Spinner, Christoph","Geisler, Fabian","Schmid, Roland M","Huber, Wolfgang"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32502643","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.cmi.2020.05.032","topics":["Case Report"],"weight":1,"_version_":1668890966392569856,"score":65.46525},{"pmid":32445626,"title":"Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19.","text":["Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19.","Lancet Respir Med","Alanio, Alexandre","Delliere, Sarah","Fodil, Sofiane","Bretagne, Stephane","Megarbane, Bruno","32445626"],"journal":"Lancet Respir Med","authors":["Alanio, Alexandre","Delliere, Sarah","Fodil, Sofiane","Bretagne, Stephane","Megarbane, Bruno"],"date":"2020-05-24T11:00:00Z","year":2020,"_id":"32445626","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/S2213-2600(20)30237-X","topics":["Case Report"],"weight":1,"_version_":1667600475804925952,"score":53.09331},{"pmid":32487793,"title":"Severe respiratory failure in an immunocompetent host with invasive pulmonary aspergillosis and H1N1 influenza.","text":["Severe respiratory failure in an immunocompetent host with invasive pulmonary aspergillosis and H1N1 influenza.","Invasive pulmonary aspergillosis (IPA) is a life-threatening condition that usually occurs in immunocompromised hosts. However, according to recent reports it can affect immunocompetent hosts with severe influenza infection due to viral-dependent disruption of respiratory immune defenses. We present the case of a 61-year-old Caucasian man admitted to the Emergency Department with respiratory failure and fever, who was diagnosed with H1N1 influenza and IPA. Because of his poor general conditions, he was treated with a double antifungal scheme, although this lies outside the suggested treatment guidelines. This choice turned out to be extremely effective. He was discharged after one month and his clinical conditions showed rapid improvement, with nearly complete normalization of the radiological pattern in three months. IPA remains a life-threatening condition, even in immunocompetent hosts, and should therefore always be suspected; if necessary, a combined treatment should rapidly be started. We report this case as the interest in influenza-associated IPA is high, both due to the clinical severity of this condition, which is treatable if identified early, and the emerging importance of respiratory infections caused by viruses belonging to the SARS family, such as SARS-CoV-2.","Infez Med","Saccaro, Luigi Francesco","Galfo, Valentina","Ferranti, Simone","Russo, Alessandro","Menichetti, Francesco","32487793"],"abstract":["Invasive pulmonary aspergillosis (IPA) is a life-threatening condition that usually occurs in immunocompromised hosts. However, according to recent reports it can affect immunocompetent hosts with severe influenza infection due to viral-dependent disruption of respiratory immune defenses. We present the case of a 61-year-old Caucasian man admitted to the Emergency Department with respiratory failure and fever, who was diagnosed with H1N1 influenza and IPA. Because of his poor general conditions, he was treated with a double antifungal scheme, although this lies outside the suggested treatment guidelines. This choice turned out to be extremely effective. He was discharged after one month and his clinical conditions showed rapid improvement, with nearly complete normalization of the radiological pattern in three months. IPA remains a life-threatening condition, even in immunocompetent hosts, and should therefore always be suspected; if necessary, a combined treatment should rapidly be started. We report this case as the interest in influenza-associated IPA is high, both due to the clinical severity of this condition, which is treatable if identified early, and the emerging importance of respiratory infections caused by viruses belonging to the SARS family, such as SARS-CoV-2."],"journal":"Infez Med","authors":["Saccaro, Luigi Francesco","Galfo, Valentina","Ferranti, Simone","Russo, Alessandro","Menichetti, Francesco"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32487793","source":"PubMed","week":"202023|Jun 01 - Jun 07","locations":["Caucasian"],"topics":["Case Report"],"weight":1,"_version_":1668623433744777216,"score":51.28058}]}